#USA #Rockville #Insilica #ToxIndex #ProtoPRED

Insilica and ProtoQSAR Team Up to Improve Chemical Safety Evaluations with ProtoPRED® Integration

In an important collaboration, Insilica, Inc. and ProtoQSAR SL have announced the integration of ProtoPRED® predictive models into ToxIndex, a platform designed to provide comprehensive chemical safety information. This partnership aims to enhance the speed and reliability of chemical risk assessments, addressing the increasing need for efficient and safe evaluation methods in light of global regulatory changes.

The Significance of the Integration

The integration between Insilica and ProtoQSAR introduces more than 60 predictive models from ProtoPRED® to ToxIndex, effectively allowing safety teams to conduct assessments swiftly and transparently. Dr. Tom Luechtefeld, CEO of Insilica, emphasized the impact of this collaboration, noting that the deployment of ProtoPRED® within ToxIndex enables teams to evaluate candidate chemicals in a matter of minutes while preserving the confidentiality of their proprietary chemical structures.

This advancement comes as regulatory agencies worldwide are accelerating the adoption of New Approach Methodologies (NAMs), which call for tools that are not only reliable but also cruelty-free. The collaborative effort signifies a robust response to these emerging needs in chemical safety.

Overview of ProtoPRED® Modules

The ProtoPRED® suite comprises various prediction models designed to meet major regulatory requirements across several domains, including:

• - ProtoICH: Focused on pharmaceutical contamination assessments (ICH M7).
• - ProtoREACH: Tailored for international regulatory evaluations, including EU REACH and K-REACH.
• - ProtoADME: Covers drug absorption and metabolism profiling.
• - ProtoPHYSCHEM: Assists in chemical and physical property profiling.
• - ProtoTOX: Offers predictions on organ and systemic toxicity.
• - ProtoECO: Provides ecotoxicological and environmental behavior predictions.
• - ProtoED: Focuses on predictions for endocrine disruptors.
• - ProtoNANO: Targets safety modeling of nanomaterials.
• - GenoITS: Integrates genotoxicity assessments.

With these tools, Insilica and ProtoQSAR are equipping safety teams with the capability to efficiently manage the increasing complexities of chemical safety evaluations.

The Future of Chemical Safety Assessments

The partnership between these two innovative companies is set to redefine the landscape of chemical safety assessments. By making a wide range of predictive models accessible within a single platform, they are not only promoting efficiency but also ensuring that safety assessments are keeping pace with the rapid advancements in regulatory frameworks and scientific understanding in toxicology.

Moreover, ProtoPRED® will be available to ToxIndex enterprise customers via an annual corporate license that includes unlimited predictions without additional fees per user or query. This approach resolves cost issues often associated with the access of predictive analytics tools, making it more feasible for organizations to adopt cutting-edge safety assessment methodologies.

In conclusion, the integration of ProtoPRED® into ToxIndex marks a significant milestone in advancing in-silico chemical evaluations. As regulatory landscapes continue to evolve, the importance of rapid, trustworthy, and humane assessment tools becomes ever more critical. Insilica and ProtoQSAR are at the forefront of this evolution, providing essential resources for organizations seeking to maintain compliance and safeguard public health.